Aurobindo Pharma said its wholly owned subsidiary, CuraTeQ Biologics, has received GMP approval from ANVISA (Agcia Nacional de Vigilcia Sanitia), Brazil's health regulator, for its biosimilars ...
PRINCETON, NJ, UNITED STATES, July 21, 2026 /EINPresswire.com/ -- PRINCETON, N.J., July 21, 2026 — Bionpharma Inc., a ...
The facility is already certified by the European Medicines Agency (EMA) and the World Health Organization (WHO).
The United States’ plan to bring imported generic medicines under a prohibitive 100% tariff from August 2028 and raise the ...
Opinion
AllAfrica on MSNOpinion
When Medicines Are Made Outside the Factory - Why Pharmacovigilance Matters More Than Ever
A high-profile court case has thrust the legalities of compounding medicines in South Africa into the spotlight. Behind the immediate legal issues hide a series of unresolved questions about how we ...
Aurobindo arm CuraTeQ gets Brazil regulatory nod for Hyderabad biosimilars facility: Our Bureau, Mumbai Wednesday, July 22, 2026, 14:15 Hrs [IST] CuraTeQ Biologics Private Limited ...
Nelipak releases 2025 sustainability report Highlights achievements aligned to sustainability vision to “help healthcare be ...
Novo Nordisk South Africa is set to launch an authorised, more affordable version of semaglutide, aimed at improving access ...
Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano today announced the publication of a comprehensive peer-reviewed study in Biomedicines describing the preclinical translational package ...
The drugmaker attributed the sharp earnings decline to a one-time semaglutide provision and the end of its lenalidomide ...
The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results